Sarcopenia (loss of muscle mass and/or strength) frequently complicates liver cirrhosis and adversely affects the quality of life; cirrhosis related liver decompensation and significantly decreases wait-list and post-liver transplantation survival. The main therapeutic strategies to improve or reverse sarcopenia include dietary interventions (supplemental calorie and protein intake), increased physical activity (supervised resistance and endurance exercises), hormonal therapy (testosterone), and ammonia lowering agents (L-ornithine L-aspartate, branch chain amino acids) as well as mechanistic approaches that target underlying molecular and metabolic abnormalities. Besides other factors, hyperammonemia has recently gained attention and increase sarcopenia by various mechanisms including increased expression of myostatin, increased phosphorylation of eukaryotic initiation factor 2a, cataplerosis of α ketoglutarate, mitochondrial dysfunction, increased reactive oxygen species that decrease protein synthesis and increased autophagy-mediated proteolysis. Sarcopenia contributes to frailty and increases the risk of minimal and overt hepatic encephalopathy.
Citations
Citations to this article as recorded by
Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS Martin Andreas Kabelitz, Simon Johannes Gairing, Anja Tiede, Eva Maria Schleicher, Liv Grete Ahl, Lea Wagner, Falko Zucker‐Reimann, Hannah Rieland, Jim Benjamin Mauz, Julia Weinmann‐Menke, Bernhard C. Meyer, Michael Bernhard Pitton, Heiner Wedemeyer, Pete Alimentary Pharmacology & Therapeutics.2026; 63(1): 109. CrossRef
Transjugular Intrahepatic Portosystemic Shunt Related Hepatic Encephalopathy in Cirrhotics With Refractory Ascites: Incidence and Correlation With TIPS Stent Diameter and Pre-TIPS Sarcopenia Amar Mukund, Vritika Bhardwaj, Ankur Jindal, Yashwant Patidar, Shiv K. Sarin Journal of Clinical and Experimental Hepatology.2026; 16(1): 103125. CrossRef
Current advances in the management of hepatic encephalopathy: an updated and critical review Bilal El-Mansoury, Hicham Esselmani, Mohamed Merzouki, Ezhilarasan Devaraj, Omar El Hiba, Arturo Ortega, Mustapha Najimi Pharmacological Reports.2026; 78(1): 173. CrossRef
Age‐related impact of outcomes in hospitalized patients with alcohol overuse Dhweeja Dasarathy, Amy H. Attaway Alcohol, Clinical and Experimental Research.2026;[Epub] CrossRef
From Shunt to Strength: Toward an Indian Model of TIPS Prehabilitation Vinay Jahagirdar, Ali Khan, Jasmohan S. Bajaj Journal of Clinical and Experimental Hepatology.2026; 16(1): 103444. CrossRef
Effectiveness of oral nutritional therapy in cirrhosis: A systematic review and meta-analysis of clinical and functional outcomes Hafiz M. Ahmed, Ubaid-ur-Rehman, Muhammad Owais Clinical Nutrition ESPEN.2026; 72: 102827. CrossRef
Gut–liver–muscle axis: linking gut microbiota dysbiosis to malnutrition and sarcopenia in liver disease Hongjing Zhao, Yang Liu, Linhao Su, Panpan Cui, Jinhai Sai, Sijin Li, Na Wang, Peiyuan He Frontiers in Medicine.2026;[Epub] CrossRef
Neurofilament light chain proteins are a sensitive biomarker of neuronal damage in cirrhotic patients with hepatic encephalopathy Clelia Asero, Francesca Polito, Maria Stella Franzé, Antonio Battaglia, Claudia Ligresti, Teresa Maltese, Irene Cacciola, M’Hammed Aguennouz, Vincenzo Macaione Frontiers in Molecular Biosciences.2026;[Epub] CrossRef
Visceral to subcutaneous fat area ratio as a novel prognostic biomarker in cirrhosis patients undergoing TIPS: a retrospective study Xiangrui Li, Qin Yin, Jiangqiang Xiao, Xiaotian Chen, Ming Zhang, Bo Gao Frontiers in Medicine.2026;[Epub] CrossRef
An Association of Covert Hepatic Encephalopathy with Non-elderly and MASLD in Patients with Chronic Liver Disease: Data-mining Analyses Dan Nakano, Yui Yamaguchi, Ayu Nagamatsu, Mayumi Ikeda, Keisuke Amano, Ryuki Hashida, Machiko Kawaguchi, Tomoya Sano, Shigemune Bekki, Tsubasa Tsutsumi, Takumi Kawaguchi Internal Medicine.2026;[Epub] CrossRef
Sarcopenia and nutritional impact in pediatric patients with chronic liver disease: Clinical and management strategies Mohit Kehar, Ana Gabriela Ayala‐German, Akash Pandey, Krupa Mysore, Amrita Narang, Sindhu Pandurangi, Anandini Suri, Bridget Whitehead, Amal Aqul, Debora Duro Journal of Pediatric Gastroenterology and Nutrition.2026;[Epub] CrossRef
Burden of malnutrition and sarcopenia in patients with cirrhosis: pathophysiology, assessment, and management Takao Miwa, Masahito Shimizu, Bernd Schnabl Clinical and Molecular Hepatology.2026; 32(2): 487. CrossRef
Prevalence and Prognostic Impact of the Coexistence of Cachexia and Sarcopenia in Patients With Chronic Liver Diseases Takatsugu Tanaka, Goki Suda, Masatsugu Ohara, Daisuke Yokoyama, Shoichi Kitano, Osamu Maehara, Tomoka Yoda, Qingjie Fu, Zijian Yang, Naohiro Yasuura, Akimitsu Meno, Takashi Sasaki, Risako Kohya, Takashi Kitagataya, Naoki Kawagishi, Masato Nakai, Takuya Sh Journal of Cachexia, Sarcopenia and Muscle.2026;[Epub] CrossRef
Nutritional aspects of prehabilitation in adults with cirrhosis awaiting liver transplant Christofer Cruz, Carla M. Prado, Chelsia Gillis, Robert Martindale, Chantal Bémeur, Jennifer C. Lai, Puneeta Tandon Hepatology.2025; 82(6): 1582. CrossRef
Body Compositions Correlate With Overt Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Wenfeng Shi, Weiguo Xu, Ningning Fan, Yong Li, Xiaoqiong Chen, Yujie Zhao, Xiao Bai, Yang Yang Journal of Clinical Gastroenterology.2025; 59(3): 262. CrossRef
Hepatic encephalopathy treatment after transjugular intrahepatic portosystemic shunt: a new perspective on the gut microbiota Xiaotong Xu, Tong Zhu, Changyou Jing, Minjie Jiang, Yunlai Fu, Fang Xie, Qinghua Meng, Jianjun Li Frontiers in Medicine.2025;[Epub] CrossRef
The Molecular Pathogenesis of Sarcopenia/Frailty in Cirrhosis Huanli Jiao, Han Wang, Jia Li, Ziyi Yang, Chao Sun Seminars in Liver Disease.2025; 45(03): 303. CrossRef
Management of hepatic encephalopathy following transjugular intrahepatic portosystemic shunts: Current strategies and future directions Ying Li, Yu-Tong Wu, Hao Wu World Journal of Gastroenterology.2025;[Epub] CrossRef
Biomedical identify the drugs between primary osteoporosis and sarcopenia Zhangxin Chen, Jianxing Lin, Zhengjin Wang Medicine.2025; 104(28): e42975. CrossRef
Metabolic and immune links between sarcopenia and liver disease Stanislav Nikolaevich Kotlyarov World Journal of Hepatology.2025;[Epub] CrossRef
Multi-omics tests identify novel shared genetic mechanisms of primary biliary cholestasis and sarcopenia Zhonghai Wang, Meiling Yu, Han Wang Scientific Reports.2025;[Epub] CrossRef
Protein and Macronutrient Metabolism in Liver Cirrhosis: About Sarcopenia Seul Ki Han, Soon Koo Baik, Moon Young Kim Nutrients.2025; 17(21): 3346. CrossRef
Sarcopenia modelling by portal vein ligation inducing hyperammonemia in rats Maria Nadinskaia, Kseniya Gulyaeva, Aleksandr Sukhinin, Alla Sedova, Polina Boykova, Ilya Izmailov, Ksenia Pokidova, Egor Kuzmin, Artem Venediktov, Igor Meglinski, Gennadii Piavchenko, Erfan Ghadirzadeh PLOS One.2025; 20(11): e0337178. CrossRef
Chronic liver diseases as a cause of sarcopenia development D. P. Kurmaev, S. V. Bulgakova, E. V. Treneva, O. V. Kosareva, P. Ya. Merzlova, L. A. Sharonova, Yu. A. Dolgikh Experimental and Clinical Gastroenterology.2025; (3): 119. CrossRef
Higher scores in the Clinical Frailty Scale are associated with covert and overt hepatic encephalopathy in patients with cirrhosis Eva Maria Schleicher, Leonard Kaps, Jörn M. Schattenberg, Peter Robert Galle, Marcus-Alexander Wörns, Simon Johannes Gairing, Christian Labenz Digestive and Liver Disease.2024; 56(6): 1046. CrossRef
The Application of Rifaximin in Patients with End Stage Liver Disease 皓月 田 Advances in Clinical Medicine.2024; 14(01): 466. CrossRef
Correlation between sarcopenia and cirrhosis: a meta-analysis Yifan Cui, Mingming Zhang, Jing Guo, Jin Jin, Haijiao Wang, Xinran Wang Frontiers in Nutrition.2024;[Epub] CrossRef
Impact of nutritional status on the outcome of transjugular intrahepatic portosystemic shunt in patients with cirrhosis: a systematic review Suprabhat Giri, Prajna Anirvan, Mansi Chaudhary, Taraprasad Tripathy, Ranjan Kumar Patel, Mitali Madhumita Rath, Manas Kumar Panigrahi British Journal of Radiology.2024; 97(1154): 331. CrossRef
Implications of Protein and Sarcopenia in the Prognosis, Treatment, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Avneet Singh, Adam Buckholz, Sonal Kumar, Carolyn Newberry Nutrients.2024; 16(5): 658. CrossRef
Shining a spotlight on sarcopenia and myosteatosis in liver disease and liver transplantation Sophie Reichelt, Uta Merle, Miriam Klauss, Christoph Kahlert, Georg Lurje, Arianeb Mehrabi, Zoltan Czigany Liver International.2024; 44(7): 1483. CrossRef
Emerging drugs for the treatment of sarcopenia in cirrhosis of the liver Simone Di Cola, Saniya Khan, Lucia Lapenna, Manuela Merli Expert Opinion on Emerging Drugs.2024; 29(2): 81. CrossRef
The protein nutritional status affects hope of patients in the terminal phase of cancer Wojciech Kolanowski, Bożena Baczewska, Krzysztof Leśniewski Medical Hypotheses.2024; 186: 111337. CrossRef
Siroz ve Malnütrisyon Merve Şatay, Sevan Çetin, İlknur Gökçe Yıldırım Kastamonu Üniversitesi Sağlık Bilimleri Fakültesi Dergisi.2024; 3(1): 11. CrossRef
Sarcopenic obesity in patients awaiting liver transplant: Unique challenges for nutritional recommendations Darya M Herscovici, Katherine M Cooper, Alessandro Colletta, Michelle Rightmyer, Alexandra Shingina, Lauren D Feld World Journal of Transplantation.2024;[Epub] CrossRef
External validation of the modified CTP score based on ammonia to predict survival in patients with cirrhosis after TIPS placement Binlin Da, Wei Wu, Wuhua Guo, Kai Xiong, Chao Chen, Qiao Ke, Moran Zhang, Taishun Li, Jiangqiang Xiao, Lei Wang, Ming Zhang, Feng Zhang, Yuzheng Zhuge Scientific Reports.2024;[Epub] CrossRef
Beyond the Liver Jiannan Huang, Ibrahim Munaf Ahmed, Tian Wang, Chencheng Xie Clinics in Liver Disease.2024; 28(4): 681. CrossRef
The effects of Qingchang Ligan formula on hepatic encephalopathy in mouse model: results from gut microbiome-metabolomics analysis Ziwei Yang, Shuhui Liu, Feili Wei, Jianhua Hu Frontiers in Cellular and Infection Microbiology.2024;[Epub] CrossRef
The Value of Ammonia as a Biomarker in Patients with Cirrhosis Maria Pilar Ballester, Esra Nur Durmazer, Tingting Qi, Rajiv Jalan Seminars in Liver Disease.2024; 44(03): 356. CrossRef
S2k-Leitlinie Klinische Ernährung in der Hepatologie Mathias Plauth, Lars Bechmann, Donata Grajecki, Felix Gundling, Ludwig Kramer, Andreas E. Kremer, Monika Rau, Andrea Schneider, Frank Tacke, Ingo van Thiel Aktuelle Ernährungsmedizin.2024; 49(04): 256. CrossRef
Sarcopenia in cirrhosis: From pathophysiology to interventional therapy Huiling Chen, Chenyun Yang, Shijie Yan, Xintao Liu, Ligang Zhou, Xinlu Yuan Experimental Gerontology.2024; 196: 112571. CrossRef
Hyperammonaemic encephalopathy due to non-functioning urea cycle as a complication to gastric bypass surgery Kristoffer Kjærgaard, Peter Lykke Eriksen, Thomas Kromann Nøhr, Steen Bønløkke Pedersen, Claus Højbjerg Gravholt, Hendrik Vilstrup, Karen Louise Thomsen Metabolic Brain Disease.2024;[Epub] CrossRef
Increased rumen Prevotella enhances BCAA synthesis, leading to synergistically increased skeletal muscle in myostatin-knockout cattle Chao Hai, Zhenting Hao, Lige Bu, Jiaru Lei, Xuefei Liu, Yuefang Zhao, Chunling Bai, Guanghua Su, Lei Yang, Guangpeng Li Communications Biology.2024;[Epub] CrossRef
Sarcopenia in the Cirrhotic Patient: Current Knowledge and Future Directions Edgewood R. Warner II, Sanjaya K. Satapathy Journal of Clinical and Experimental Hepatology.2023; 13(1): 162. CrossRef
Correspondence on Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis” Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim Clinical and Molecular Hepatology.2023; 29(1): 173. CrossRef
Nutrition in Viral Hepatitis Dibya L. Praharaj, Anil C. Anand Current Hepatology Reports.2023; 22(1): 9. CrossRef
Enteral nutrition product formulations: A review of available products and indications for use April Church, Steph Zoeller Nutrition in Clinical Practice.2023; 38(2): 277. CrossRef
Sarcopenia and Frailty in Cirrhosis Chalermrat Bunchorntavakul Medical Clinics of North America.2023; 107(3): 589. CrossRef
Methionine adenosyltransferase2A inhibition restores metabolism to improve regenerative capacity and strength of aged skeletal muscle Nika Rajabian, Izuagie Ikhapoh, Shahryar Shahini, Debanik Choudhury, Ramkumar Thiyagarajan, Aref Shahini, Joseph Kulczyk, Kendall Breed, Shilpashree Saha, Mohamed Alaa Mohamed, Susan B. Udin, Aimee Stablewski, Kenneth Seldeen, Bruce R. Troen, Kirkwood Per Nature Communications.2023;[Epub] CrossRef
Breath-by-breath measurement of exhaled ammonia by acetone-modifier positive photoionization ion mobility spectrometry via online dilution and purging sampling Lu Wang, Dandan Jiang, Lei Hua, Chuang Chen, Dongming Li, Weiguo Wang, Yiqian Xu, Qimu Yang, Haiyang Li, Song Leng Journal of Pharmaceutical Analysis.2023; 13(4): 412. CrossRef
Quick surface adsorption and sensing of ammonia at room temperature by In2S3 thin films Sumit Kumar, Teny Theresa John Applied Surface Science.2023; 620: 156816. CrossRef
Prediction and prevention of the first episode of overt hepatic encephalopathy in patients with cirrhosis Simon J. Gairing, Eva M. Schleicher, Peter R. Galle, Christian Labenz Hepatology Communications.2023;[Epub] CrossRef
Visión actual sobre el diagnóstico y los cuidados integrales en la encefalopatía hepática F. Higuera-de-la-Tijera, J.A. Velarde-Ruiz Velasco, R.H. Raña-Garibay, G.E. Castro-Narro, J.M. Abdo-Francis, R. Moreno-Alcántar, J.L. Pérez-Hernández, A. Torre, R. Contreras-Omaña, A. Cano-Contreras, M. Castillo-Barradas, J. Pérez-Escobar, J.M. Aldana-Led Revista de Gastroenterología de México.2023; 88(2): 155. CrossRef
Current vision on diagnosis and comprehensive care in hepatic encephalopathy F. Higuera-de-la-Tijera, J.A. Velarde-Ruiz Velasco, R.H. Raña-Garibay, G.E. Castro-Narro, J.M. Abdo-Francis, R. Moreno-Alcántar, J.L. Pérez-Hernández, A. Torre, R. Contreras-Omaña, A. Cano-Contreras, M. Castillo-Barradas, J. Pérez-Escobar, J.M. Aldana-Led Revista de Gastroenterología de México (English Edition).2023; 88(2): 155. CrossRef
A Prospective Study of Prevalence and Impact of Sarcopenia on Short-term Mortality in Hospitalized Patients with Liver Cirrhosis Surakshith Thyloor Kenchappa, Samarth Sharma, Mandhir Kumar, Samarjit S. Ghuman, Anil Arora, Piyush Ranjan Journal of Clinical and Experimental Hepatology.2023; 13(6): 946. CrossRef
A modified Child-Turcotte-Pugh score based on plasma ammonia predicts survival for patients with decompensated cirrhosis X Wang, M Zhang, J Xiao, W Zhang, Y Wang, S Zhang, X Zou, L Wang, Y Zhuge, F Zhang QJM: An International Journal of Medicine.2023; 116(6): 436. CrossRef
Potential Benefits of Epidermal Growth Factor for Inhibiting Muscle Degrative Markers in Rats with Alcoholic Liver Damage Qian Xiao, Yi-Hsiu Chen, Ya-Ling Chen, Yu-Shan Chien, Li-Hsuan Hsieh, Hitoshi Shirakawa, Suh-Ching Yang International Journal of Molecular Sciences.2023; 24(10): 8845. CrossRef
Sarcopenia in chronic viral hepatitis: From concept to clinical relevance Marta Paula Pereira Coelho, Pedro Alves Soares Vaz de Castro, Thaís Pontello de Vries, Enrico Antônio Colosimo, Juliana Maria Trindade Bezerra, Gifone Aguiar Rocha, Luciana Diniz Silva World Journal of Hepatology.2023; 15(5): 649. CrossRef
GDF8 Contributes to Liver Fibrogenesis and Concomitant Skeletal Muscle Wasting Alexander Culver, Matthew Hamang, Yan Wang, Huaizhou Jiang, Jennifer Yanum, Emily White, Samer Gawrieh, Raj K. Vuppalanchi, Naga P. Chalasani, Guoli Dai, Benjamin C. Yaden Biomedicines.2023; 11(7): 1909. CrossRef
Investigation of Changes in Skeletal Muscle Mass and Muscle Quality and Factors Affecting Changes in Deceased Donor Liver Transplantation Hirokazu Onishi, Ryo Yoshikawa, Risa Harada, Tsuyoshi Matsumoto, Tetsuro Kurashina, Akimasa Adachi, Yasumitsu Fujii, Kaori Kuramitsu, Takumi Fukumoto, Yoshitada Sakai Transplantation Proceedings.2023; 55(7): 1649. CrossRef
Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov, Vladimir Ivashkin World Journal of Gastroenterology.2023; 29(27): 4236. CrossRef
Case 30-2023: A 50-Year-Old Woman with Confusion Richard C. Cabot, Eric S. Rosenberg, David M. Dudzinski, Meridale V. Baggett, Kathy M. Tran, Dennis C. Sgroi, Jo-Anne O. Shepard, Emily K. McDonald, Tara Corpuz, Amulya Nagarur, Theodore T. Pierce, Andrew Z. Fenves, Elan R. Witkowski, Nina B. Gold New England Journal of Medicine.2023; 389(13): 1221. CrossRef
Pretransplant Functional Status Predicts Postoperative Morbidity and Mortality after Liver Transplantation in Patients with Cirrhosis Myung Ji Goh, Jihye Kim, Won Hyuk Chang, Dong Hyun Sinn, Geum-Yeon Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Jong Man Kim, Wonseok Kang Gut and Liver.2023; 17(5): 786. CrossRef
Association between sarcopenia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: a systematic review and meta-analysis Yuanyuan Li, Yuxin Guo, Xiaoze Wang, Langli Gao Abdominal Radiology.2023; 49(2): 575. CrossRef
Portal Hypertension in Malnutrition and Sarcopenia in Decompensated Cirrhosis—Pathogenesis, Implications and Therapeutic Opportunities Ryma Terbah, Adam Testro, Paul Gow, Avik Majumdar, Marie Sinclair Nutrients.2023; 16(1): 35. CrossRef
Research Progress of Blood-Derived Biomarkers Predicting Prognosis of Liver Cirrhosis 晓丽 胡 Advances in Clinical Medicine.2023; 13(12): 19716. CrossRef
Effects of branched-chain amino acid-rich supplementation on EWGSOP2 criteria for sarcopenia in older adults: a systematic review and meta-analysis Geng-Hao Bai, Meng-Chen Tsai, Han-Wei Tsai, Chun-Chao Chang, Wen-Hsuan Hou European Journal of Nutrition.2022; 61(2): 637. CrossRef
Predictors of Sarcopenia in an Obese Asian Population Min Je Sung, Jun Yong Park, Hye Won Lee, Beom Kyung Kim, Do Young Kim, Sang Hoon Ahn, Seung Up Kim Nutrition and Cancer.2022; 74(2): 505. CrossRef
Psoas Muscle Density Predicts Occurrences of Hepatic Encephalopathy in Patients Receiving Transjugular Intrahepatic Portosystemic Shunts within 1 year Weimin Cai, Hanyu Lin, Ruyi Qi, Xinran Lin, Yuan Zhao, Weizhen Chen, Zhiming Huang CardioVascular and Interventional Radiology.2022; 45(1): 93. CrossRef
Effects of Branched-Chain Amino Acids on Parameters Evaluating Sarcopenia in Liver Cirrhosis: Systematic Review and Meta-Analysis Abdulrahman Ismaiel, Camelia Bucsa, Andreea Farcas, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Dan L. Dumitrascu Frontiers in Nutrition.2022;[Epub] CrossRef
Ammonia and the Muscle: An Emerging Point of View on Hepatic Encephalopathy Simone Di Cola, Silvia Nardelli, Lorenzo Ridola, Stefania Gioia, Oliviero Riggio, Manuela Merli Journal of Clinical Medicine.2022; 11(3): 611. CrossRef
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management Paolo Gallo, Marianna Silletta, Antonio De Vincentis, Federica Lo Prinzi, Francesca Terracciani, Giuseppina Di Fazio, Valentina Flagiello, Umberto Vespasiani Gentilucci, Raffaele Antonelli Incalzi, Antonio Picardi Chemotherapy.2022; 67(3): 152. CrossRef
Effects of supervised exercise on aerobic capacity and quality of life in patients with chronic liver disease and patients who underwent liver transplantation: a systematic review and meta-analysis Yoo Jin Choo, Chan Woo Cho, Min Cheol Chang International Journal of Rehabilitation Research.2022; 45(1): 1. CrossRef
Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis Ji Won Han, Da In Kim, Hee Chul Nam, U Im Chang, Jin Mo Yang, Do Seon Song Clinical and Molecular Hepatology.2022; 28(2): 219. CrossRef
Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis Takumi Kawaguchi, Takuji Torimura Clinical and Molecular Hepatology.2022; 28(2): 177. CrossRef
The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls Hae Lim Lee, Sung Won Lee Clinical and Molecular Hepatology.2022; 28(2): 121. CrossRef
Amino acids, ammonia, and hepatic encephalopathy Katerina Kroupina, Chantal Bémeur, Christopher F. Rose Analytical Biochemistry.2022; 649: 114696. CrossRef
Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy Myung Ji Goh, Wonseok Kang, Woo Kyoung Jeong, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik Scientific Reports.2022;[Epub] CrossRef
Hepatic encephalopathy Dieter Häussinger, Radha K. Dhiman, Vicente Felipo, Boris Görg, Rajiv Jalan, Gerald Kircheis, Manuela Merli, Sara Montagnese, Manuel Romero-Gomez, Alfons Schnitzler, Simon D. Taylor-Robinson, Hendrik Vilstrup Nature Reviews Disease Primers.2022;[Epub] CrossRef
The sex‐specific prognostic utility of sarcopenia in cirrhosis Ryan Lowe, Penelope Hey, Marie Sinclair Journal of Cachexia, Sarcopenia and Muscle.2022; 13(6): 2608. CrossRef
Impact of L-ornithine L-aspartate on non-alcoholic steatohepatitis-associated hyperammonemia and muscle alterations Camille Pichon, Maxime Nachit, Justine Gillard, Greetje Vande Velde, Nicolas Lanthier, Isabelle A. Leclercq Frontiers in Nutrition.2022;[Epub] CrossRef
Hepatic Encephalopathy Vickie Reed Critical Care Nursing Clinics of North America.2022; 34(3): 331. CrossRef
Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim, Joo Won Baik, Sun Young Yim, Young-Sun Lee, Yeon Seok Seo, Ji Hoon Kim, Jong Eun Yeon, Kwan Soo Byun Clinical and Molecular Hepatology.2022; 28(4): 876. CrossRef
Skeletal muscle mass index as a predictor of long-term cirrhosis onset in young non-cirrhotic males with acute-on-chronic liver failure Jie Bai, Manman Xu, Fengling Peng, Junwei Gong, Jinqiu Zhao, Xiaodong Song, Yongguo Li Frontiers in Nutrition.2022;[Epub] CrossRef
Hyperammonemia in azotemic cats Lauren Carvalho, Denise Kelley, Mary Anna Labato, Cynthia RL Webster Journal of Feline Medicine and Surgery.2021; 23(8): 700. CrossRef
Glucagon Receptor Inhibition Reduces Hyperammonemia and Lethality in Male Mice with Urea Cycle Disorder Katie Cavino, Biin Sung, Qi Su, Erqian Na, Jinrang Kim, Xiping Cheng, Jesper Gromada, Haruka Okamoto Endocrinology.2021;[Epub] CrossRef
Molecular Mechanisms and Treatment of Sarcopenia in Liver Disease: A Review of Current Knowledge Hiroteru Kamimura, Takeki Sato, Kazuki Natsui, Takamasa Kobayashi, Tomoaki Yoshida, Kenya Kamimura, Atsunori Tsuchiya, Toshiko Murayama, Junji Yokoyama, Hirokazu Kawai, Masaaki Takamura, Shuji Terai International Journal of Molecular Sciences.2021; 22(3): 1425. CrossRef
An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia Young Joo Yang, Dong Joon Kim International Journal of Molecular Sciences.2021; 22(5): 2604. CrossRef
Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Ho Soo Chun, Sojeong Park, Minjong Lee, Yuri Cho, Ha Sung Kim, A Reum Choe, Hwi Young Kim, Kwon Yoo, Tae Hun Kim Cancers.2021; 13(14): 3424. CrossRef
Definition of Sarcopenia in Chronic Liver Disease Seong Wan Son, Do Seon Song, U Im Chang, Jin Mo Yang Life.2021; 11(4): 349. CrossRef
Skeletal muscle atrophy: From mechanisms to treatments Lin Yin, Na Li, Weihua Jia, Nuoqi Wang, Meidai Liang, Xiuying Yang, Guanhua Du Pharmacological Research.2021; 172: 105807. CrossRef
Identifying areas of improvement in nursing knowledge regarding hepatic encephalopathy management Aalam Sohal, Victoria Green, Sunny Sandhu, Marina Roytman Journal of Community Hospital Internal Medicine Perspectives.2021; 11(5): 722. CrossRef
Hepatische Enzephalopathie und Sarkopenie: pathogenetische Bedeutung und therapeutische Implikationen von Ammoniak M. Kluge, M. Demir, Frank Tacke Der Gastroenterologe.2021; 16(3): 160. CrossRef
Synbiotics Alleviate Hepatic Damage, Intestinal Injury and Muscular Beclin-1 Elevation in Rats after Chronic Ethanol Administration Yi-Hsiu Chen, Wan-Chun Chiu, Qian Xiao, Ya-Ling Chen, Hitoshi Shirakawa, Suh-Ching Yang International Journal of Molecular Sciences.2021; 22(22): 12547. CrossRef
Systematic computer analysis of ornithine research to identify the most promising trends in therapeutic use - focus on liver function O. A. Gromova, I. Yu. Torshin, L. B. Lazebnik, V. A. Maksimov Experimental and Clinical Gastroenterology.2021; (7): 30. CrossRef
Exercise and physical activity in cirrhosis: opportunities or perils Annette Bellar, Nicole Welch, Srinivasan Dasarathy Journal of Applied Physiology.2020; 128(6): 1547. CrossRef
Liver fibrosis score, physical frailty, and the risk of dementia in older adults: The Italian Longitudinal Study on Aging Vincenzo Solfrizzi, Emanuele Scafato, Carlo Custodero, Francesca Loparco, Alessandro Ciavarella, Francesco Panza, Davide Seripa, Bruno Pietro Imbimbo, Madia Lozupone, Nicola Napoli, Giuseppina Piazzolla, Lucia Galluzzo, Claudia Gandin, Marzia Baldereschi, Alzheimer's & Dementia: Translational Research & Clinical Interventions.2020;[Epub] CrossRef
Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study Ji Hyun Kim, Seong Hee Kang, Minjong Lee, Gi Soo Youn, Tae Suk Kim, Baek Gyu Jun, Moon Young Kim, Young Don Kim, Gab Jin Cheon, Dong Joon Kim, Soon Koo Baik, Dae Hee Choi, Ki Tae Suk Cancers.2020; 12(11): 3347. CrossRef
Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis B Kyung Hyun Kim, Dong Jin Joo, Yong-ho Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim Digestive and Liver Disease.2020; 52(11): 1338. CrossRef
Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis Daniela Campion, Ilaria Giovo, Paola Ponzo, Giorgio M Saracco, Federico Balzola, Carlo Alessandria World Journal of Hepatology.2019; 11(6): 489. CrossRef